Which blood biomarkers actually matter for longevity?

Short answer: several routine and a few advanced blood biomarkers are consistently linked to long-term mortality and healthy lifespan. The most useful ones are those that track metabolic health, atherosclerotic risk, inflammation, kidney/liver function, oxygen-carrying capacity, and key micronutrient deficiencies. Focus first on modifiable, well‑validated tests (glucose control, ApoB/LDL, inflammation, kidney function, A1c), then add advanced tests (LDL‑particle number, Lp(a), NMR/GlycA, cystatin C) if you want deeper risk stratification.

Below is a practical, prioritized list with why each matters, typical “good” targets (approximate — individual targets vary), and how to improve results.

Top priorities

• Hemoglobin A1c (HbA1c) and fasting glucose / fasting insulin

  • Why: Chronic hyperglycemia and insulin resistance predict diabetes, cardiovascular disease, dementia, and higher mortality.
  • Rough target: HbA1c in the non‑diabetic range (generally <5.7%); many healthy people target ~5.0–5.6%. Fasting glucose <100 mg/dL. Lower fasting insulin / HOMA‑IR indicates better insulin sensitivity.
  • How to improve: weight loss, improved diet (lower refined carbs), resistance + aerobic exercise, sleep, and medications when appropriate (metformin, GLP‑1 agonists).

• Lipids with particle measures: ApoB, LDL‑particle number (LDL‑P), LDL‑C, non‑HDL, triglycerides, HDL

  • Why: Atherosclerotic cardiovascular disease (the leading cause of death) is best tracked by particle burden (ApoB/LDL‑P) rather than LDL‑C alone.
  • Rough target: ApoB <80 mg/dL (lower if high risk), LDL‑P and non‑HDL as low as your risk profile warrants (many high‑risk patients aim LDL <70 mg/dL). Triglycerides <150 mg/dL; HDL higher is usually better.
  • How to improve: diet quality, weight loss, statins/ezetimibe/PCSK9 inhibitors as indicated, exercise, reduce refined carbs and alcohol.

Important and actionable

• High‑sensitivity CRP (hs‑CRP) and other inflammation markers (IL‑6, GlycA)

  • Why: Chronic low‑grade inflammation (“inflammaging”) predicts mortality, cardiovascular events, and disability.
  • Rough target: hs‑CRP <1 mg/L is low risk; 1–3 mg/L moderate; >3 mg/L higher risk.
  • How to improve: weight loss, exercise, smoking cessation, statins, dietary improvements; specific anti‑inflammatory drugs are used in selected cases but are not routine.

• Lipoprotein(a) — Lp(a)

  • Why: Strong genetic driver of atherosclerotic and valvular disease; one‑time test is usually enough because levels are largely inherited.
  • Rough target: ideally <30–50 nmol/L (or <30–50 mg/dL depending on units); elevated levels merit specialist input.
  • How to improve: limited; some PCSK9 inhibitors modestly lower Lp(a); new therapies (antisense oligonucleotides) are in development.

• Kidney function: serum creatinine/eGFR, cystatin C, urine albumin‑to‑creatinine ratio (UACR)

  • Why: Reduced kidney function and albuminuria strongly predict cardiovascular disease and death.
  • Rough target: eGFR >60 mL/min/1.73m2; UACR <30 mg/g.
  • How to improve: blood pressure control (ACEi/ARB), glycemic control, avoid nephrotoxins, treat underlying causes.

• Complete blood count components — hemoglobin, hematocrit, RDW (red cell distribution width), WBC

  • Why: Low hemoglobin (anemia) and high RDW/WBC count associate with higher mortality and frailty.
  • How to improve: identify causes (iron/B12 deficiency, chronic disease), treat appropriately.

• Liver enzymes and markers of fatty liver (ALT, AST, GGT, fasting triglycerides)

  • Why: NAFLD and elevated GGT/ALT associate with metabolic disease and worse long‑term outcomes.
  • How to improve: weight loss, exercise, treat metabolic syndrome.

Useful micronutrients / endocrine markers

• 25‑hydroxy vitamin D
  • Why: Very low levels associate with poor health; supplementation corrects deficiency.
  • Typical target: 30–50 ng/mL for most adults (individualize).
• Vitamin B12/folate, ferritin (if indicated)
  • Why: Deficiencies cause anemia, neuropathy, and poor functional outcomes.
• Thyroid tests (TSH, free T4; free T3 if symptomatic)
  • Why: Untreated hypo/hyperthyroidism affects metabolism, cognition, and cardiovascular risk.

Advanced/specialty markers (for deeper risk stratification)

• ApoB and LDL‑P (NMR or apoB lab)
  • Why: Better predictors of atherosclerotic risk than LDL‑C alone.
  • How to get it: NMR Lipoprofile (LabCorp), ApoB via Quest or LabCorp, or advanced lipid panels from specialty labs.
• GlycA (NMR inflammation signal), IL‑6, TNF‑alpha
  • Why: Emerging, strong predictors of long‑term risk and frailty.
• Cystatin C (refined eGFR) and urine biomarkers for earlier kidney disease detection.

How often to test

• Healthy adults: basic panels (CBC, CMP, fasting lipids, HbA1c) annually.
• If abnormalities or higher risk: every 3–6 months while optimizing or on therapy.
• One‑time tests: Lp(a) (once unless family history or therapy change), ApoB/LDL‑P if you want a better baseline.

Practical next steps (what I’d recommend)

• Start with: fasting metabolic panel + lipid panel + HbA1c + hs‑CRP + CBC + kidney/liver tests + vitamin D. Add ApoB or NMR/LDL‑P if you want precise CV risk.
• If you have personal/family CVD or early CVD: add Lp(a) and consider referral to a lipid specialist.

Where to get these tests (brands/services)

• LabCorp and Quest Diagnostics — widely available, full panels and specialty tests (ApoB, Lp(a), NMR LipoProfile via LabCorp).
• InsideTracker or WellnessFX — consumer‑facing platforms that combine lab testing with personalized interpretation and lifestyle recommendations.
• Nightingale Health — advanced NMR metabolomics (more common in Europe) for GlycA and detailed metabolite profiling.
• Everlywell or LetsGetChecked — convenient home sample kits for common tests (A1c, lipids, vitamin D, etc.) if you prefer at‑home draws.
• Local primary care or a preventive cardiology/lipid clinic — for interpretation and prescription decisions (statins, BP meds, advanced therapies).

Cautions

• Associations ≠ causation: some markers predict risk but lowering them does not always change outcomes (interpret with clinician).
• Targets must be individualized by age, sex, comorbidities, and medications; very low values in older adults can sometimes be harmful.
• Don’t chase single numbers — focus on overall risk reduction: blood pressure control, smoking cessation, body composition, cardiorespiratory fitness, good sleep, diet, and control of diabetes/lipids.

If you want, tell me your age, sex, major medical history, and any recent lab results and I’ll prioritize which tests to get and give more specific target ranges and action steps.